{"id":"NCT02651584","sponsor":"Braeburn Pharmaceuticals","briefTitle":"Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence","officialTitle":"A Phase III, Randomized, Double-Blind, Active-Controlled, Parallel Group, Multi-center Trial Assessing the Efficacy and Safety of a Once-Weekly and Once-Monthly, Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Treatment of Adult Outpatients With Opioid Use Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-12","primaryCompletion":"2016-10","completion":"2016-11","firstPosted":"2016-01-11","resultsPosted":"2019-08-22","lastUpdate":"2019-08-22"},"enrollment":428,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Opioid Use Disorders"],"interventions":[{"type":"DRUG","name":"CAM2038 SC injection","otherNames":["Buprenorphine injection"]},{"type":"DRUG","name":"SL BPN/NX tabs","otherNames":["Suboxone"]},{"type":"DRUG","name":"placebo SC injections","otherNames":["placebo"]},{"type":"DRUG","name":"SL placebo tablets","otherNames":["placebo"]}],"arms":[{"label":"SL BPN/NX tabs + placebo SC injections","type":"EXPERIMENTAL"},{"label":"CAM2038 SC injections + SL placebo tabs","type":"EXPERIMENTAL"}],"summary":"Phase III, randomized, double-blind, double-dummy, active-controlled, parallel group multi-center trial, designed to evaluate the non-inferiority of CAM2038 compared to an existing standard of care (SL BPN/NX) in initiation and maintenance treatment with BPN.","primaryOutcome":{"measure":"Response Rate, Denoted by Response Rate (Weeks 1-24).","timeFrame":"24 weeks","effectByArm":[{"arm":"Group 1: SL BP/NX Tablets + Placebo SC Injections","deltaMin":31,"sd":null},{"arm":"Group 2: CAM2038 SC Injections + SL Placebo Tablets","deltaMin":37,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":36,"countries":["United States"]},"refs":{"pmids":["39629836","38916892","29799968"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":215},"commonTop":["Injection site pain","Headache","Constipation","Nausea","Injection site pruritus"]}}